Skip Navigation



Hum. Reprod. Advance Access published online on January 28, 2008

Human Reproduction, doi:10.1093/humrep/dem432
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
23/4/919    most recent
dem432v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Emaus, A.
Right arrow Articles by Thune, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Emaus, A.
Right arrow Articles by Thune, I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

17-β-Estradiol in relation to age at menarche and adult obesity in premenopausal women

A. Emaus1,10, S. Espetvedt1, M.B. Veierød2, R. Ballard-Barbash3, A.-S. Furberg4,5, P.T. Ellison6, G. Jasienska7, A. Hjartåker8 and I. Thune1,9

1 Department of Oncology, Ullevål University Hospital, 0407 Oslo, Norway 2 Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway 3 Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, EPN 4005, 6130 Executive Boulevard, MSC 7344, Bethesda, MD 20892-7344, USA 4 NORM Surveillance Program for Antimicrobial Resistance in Human Pathogens, Department of Microbiology and Infection Control, University Hospital of North Norway, N-9038 Tromsø, Norway 5 Institute of Community Medicine, Faculty of Medicine, University of Tromsø, N-9037 Tromsø, Norway 6 Department of Anthropology, Harvard University, 11 Divinity Avenue, Cambridge, MA 02138, USA 7 Department of Epidemiology and Population Studies, Jagiellonian University, Collegium Medicum, Krakow, Poland 8 Institute of Population-Based Cancer Research, Cancer Registry of Norway, Montebello, N-0310 Oslo, Norway 9 The Research Council of Norway, PO Box 2700, St Hanshaugen, N-0131 Oslo, Norway

10 Correspondence address. Tel: +47-95-93-06-82; Fax: +47-23-02-68-31; E-mail: aina.emaus{at}medisin.uio.no

BACKGROUND: We hypothesize that premenopausal endogenous estradiol may be associated with age at menarche and adult overweight and obesity, potentially contributing to breast cancer risk.

METHODS: We assessed age at menarche by questionnaire among 204 healthy Norwegian women, aged 25–35 years. Measures of body composition included body mass index (BMI, kg/m2), waist circumference (WC, cm), waist-to-hip ratio (WHR) and fat percentage dual energy X-ray absorptiometry, (DEXA). Daily salivary 17-β-estradiol (E2) concentrations were collected throughout one entire menstrual cycle and assessed by radioimmunoassay (RIA). Linear regression analyses and linear mixed models for repeated measures were used and potential confounding factors and effect modifiers were tested.

RESULTS: Among women with an early age at menarche (≤12 years), the overall mean salivary E2 concentration increased by 3.7 pmol/l (95% confidence interval, 1.8–5.7 pmol/l) with each 9.8 cm (1 SD) increase in WC, which represents a 20.7% change in the mean for the total group. Among the same early maturers, a 1 SD (0.06) change in WHR was directly associated with a 24.0% change in mean E2 concentration for the total group.

CONCLUSIONS: Our findings support the hypothesis that early age at menarche, together with adult overweight and obesity, result in high levels of 17-β-estradiol throughout the menstrual cycle.

Key words: 17-β-estradiol/age at menarche/adult body fatness/breast cancer risk/Norway

Submitted on August 29, 2007; resubmitted on November 28, 2007; accepted on December 20, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. E. Finstad, A. Emaus, S. Tretli, G. Jasienska, P. T. Ellison, A.-S. Furberg, E. A. Wist, and I. Thune
Adult Height, Insulin, and 17{beta}-Estradiol in Young Women
Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1477 - 1483.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Zipprich, M. B. Terry, Y. Liao, M. Agrawal, I. Gurvich, R. Senie, and R. M. Santella
Plasma Protein Carbonyls and Breast Cancer Risk in Sisters Discordant for Breast Cancer from the New York Site of the Breast Cancer Family Registry
Cancer Res., April 1, 2009; 69(7): 2966 - 2972.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.